Evidence map›Paper›PMID 37239875›Full record

ArticleInternational journal of molecular sciences2023

Effect of Functional Nanoporous TiO

Lidia Benea, Anca Ravoiu Lupu, Iulian Bounegru, Petrica Vizureanu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Three-Dimensional Titanium Substrates with Anodic TiOMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lidia BeneaCompetences Center: Interfaces-Tribocorrosion-Electrochemical Systems, Dunarea de Jos University of Galati, 47 Domnească Street, RO-800008 Galati, Romania.ORCID 0000-0003-1551-3960
Anca Ravoiu LupuCompetences Center: Interfaces-Tribocorrosion-Electrochemical Systems, Dunarea de Jos University of Galati, 47 Domnească Street, RO-800008 Galati, Romania.
Iulian BounegruCompetences Center: Interfaces-Tribocorrosion-Electrochemical Systems, Dunarea de Jos University of Galati, 47 Domnească Street, RO-800008 Galati, Romania.ORCID 0000-0002-8007-9120
Petrica VizureanuFaculty of Materials Science and Engineering, "Gheorghe Asachi" Technical University of Iasi, RO-700050 Iasi, Romania.
"Dunarea de Jos" University of Galati · ROGheorghe Asachi Technical University of Iași · RO

Funding

Unitatea Executiva Pentru Finantarea Invatamantului Superior Si A Cercetarii Stiintifice Universitare PCE 102/2022
6 · The paper itself

Abstract

The metallic titanium-based biomaterials are sensitive to corrosion-induced degradation in biological fluids in the presence of inflammatory conditions containing reactive oxygen species (ROS). Excess ROS induces oxidative modification of cellular macromolecules, inhibits protein function, and promotes cell death. In addition, ROS could promote implant degradation by accelerating the corrosive attack of biological fluids. The functional nanoporous titanium oxide film is obtained on titanium alloy to study the effect on implant reactivity in biological fluid with reactive oxygen species such as hydrogen peroxide, which are present in inflammations. The TiO

Indexed as

NanoporesTitaniumAlloysCorrosionHydrogen PeroxideMaterials TestingReactive Oxygen SpeciesSurface PropertiesAlloysHydrogen PeroxideReactive Oxygen SpeciesTitaniumtitanium alloy (TiAl6V4)titanium dioxidebiologic fluidbiomaterialscorrosioninflammatory compoundreactive oxygen species

Identifiers

PMID37239875
PMCPMC10218300
OpenAlexW4376115274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.